EBITDA Margin ratio Analysis of Silverback Therapeutics Inc - Deep Dive
Birds's Eye
Fundamentals
Fundamentals
Technicals
MovingAverage
Candlestick
PivotPointLatest FY EBITDA Margin
Period Ending - Dec-23
Very Poor EBITDA Margin
-204220.00
Period Ending - Dec-22
Very Poor EBITDA Margin
-2635.41
Growth
-7649.08 %
Trailing Twelve Months EBITDA Margin
Period Ending - Dec-23
Excellent EBITDA Margin
293715
Most recent Quarter EBITDA Margin
Period Ending - Mar-24
Poor EBITDA Margin
0
EBITDA Margin Analysis of Silverback Therapeutics Inc
| Ebitda Margin Ratio of Silverback Therapeutics Inc with value of 293715 means that its operating expenses are lower in relation to total revenue in trailing twelve months. |
| EBITDA Margin Ratio of SPRY drastically fell by -7649.08 % this year. |
| EBITDA Margin Ratio with value of 0 was highest in Year Dec-19 in last Five Years. |
| EBITDA Margin Ratio of SPRY trending down for at least three Years. |
| Latest EBITDA Margin Ratio with value of -204220.00 is lower than Average EBITDA Margin of -41445.78 in last five years. |
| Ebitda Margin of Silverback Therapeutics Inc is negative because of negative EBITDA in FY ended on Dec-23. |
Other EBITDA Margin Related Info of SPRY that may interest you.
Silverback Therapeutics Inc Overview
| Code | Price | Previous Price | Price Change | Sector |
|---|---|---|---|---|
| SPRY | 8.41 | 8.66 | 2.89 % | Biotechnology |
Defination of EBITDA Margin
EBITDA Margin is the profitability ratio that measures a company's earnings before interest, taxes, depreciation, and amortization as a percentage of revenue. EBITDA is the abbreviation for Earnings before Interest, Taxes, Depreciation, and Amortization. more ..
EBITDA Margin Related Ratios
| NetProfitMargin | ReturnOnEquity |
Tsr Profitability Index
| Poor Profitability Stock | |
FY - Historical EBITDA Margin of Silverback Therapeutics Inc
| Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 |
|---|---|---|---|---|---|
| EBITDA Margin | -204220.00 | -2635.41 | -367.54 | -5.94 | 0 |
| Change | -7649.08 % | -617.03 % | -6089.95 % |
FY Chart of EBITDA Margin of Silverback Therapeutics Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)